An international group of medical editors is challenging several leading pharmaceutical companies, saying that their reporting of clinical trials is deliberately incomplete.The International Committee of Medical Journal Editors made their complaint in an editorial in The New England Journal of Medicine, published online on 23 May. EXCLUSION: Focus on reporting trials
CITATION STYLE
Wadman, M. (2005). Drug giants fail to name compounds in trial database. Nature, 435(7042), 548–548. https://doi.org/10.1038/435548b
Mendeley helps you to discover research relevant for your work.